The search found 3784 results.
News
Blog
Learn how leading New York hospitals are critically thinking about, and planning for, I-STOP's mandatory introduction of EPCS processes.
Press
Latest Version of Imprivata OneSign Improves Scalability and Expands Market-Leading Support for Desktop Virtualization Platforms and Thin/Zero Clients Lexington, Mass.—December 2, 2014—Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced Imprivata OneSign® 5.0, the newest version of the company’s flagship authentication and access management solution.
Video
This video highlights the benefits of electronic prescribing of controlled substances (EPCS) and provides an overview of the DEA regulatory requirements for EPCS.
Blog
Electronic prescribing of controlled substances (EPCS) has many benefits for prescribers, patients, IT, and pharmacy and hospital administration. But the DEA requirements for EPCS introduce complexities that need to be considered when developing a project plan.
Video
Methodist Health System (Omaha, Neb.) leverages fingerprint biometric authentication from Imprivata to enable e-Prescribing of controlled substances to improve patient satisfaction, eliminate dual-prescribing workflows and address drug diversion.
Blog
Learn how to successfully implement a new clinical communications solution: Listen to your clinical crew and empower them to rally together effectively
Blog
Ensure EPCS success by following these six comprehensive steps. Deploying Electronic Prescribing of Controlled Substances shouldn't be a headache.